ATA575574A - Verfahren zur herstellung von neuen 1,3-oxygenierten 8alfa-oestratrienen - Google Patents

Verfahren zur herstellung von neuen 1,3-oxygenierten 8alfa-oestratrienen

Info

Publication number
ATA575574A
ATA575574A AT575574A AT575574A ATA575574A AT A575574 A ATA575574 A AT A575574A AT 575574 A AT575574 A AT 575574A AT 575574 A AT575574 A AT 575574A AT A575574 A ATA575574 A AT A575574A
Authority
AT
Austria
Prior art keywords
oestratria
8alfa
oxygenated
preparing new
preparing
Prior art date
Application number
AT575574A
Other languages
German (de)
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2336431A external-priority patent/DE2336431C2/de
Priority claimed from DE19742426777 external-priority patent/DE2426777A1/de
Application filed by Schering Ag filed Critical Schering Ag
Priority to AT868776A priority Critical patent/ATA868776A/de
Publication of ATA575574A publication Critical patent/ATA575574A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
AT575574A 1973-07-13 1974-07-11 Verfahren zur herstellung von neuen 1,3-oxygenierten 8alfa-oestratrienen ATA575574A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT868776A ATA868776A (de) 1973-07-13 1976-11-23 Verfahren zur herstellung von neuen 1,3-oxygenierten 8alfa-oestratrienen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2336431A DE2336431C2 (de) 1973-07-13 1973-07-13 1.3-oxygenierte 8 alpha-Östratriene, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19742426777 DE2426777A1 (de) 1974-05-31 1974-05-31 1.3-oxygenierte 8 alpha-oestratriene

Publications (1)

Publication Number Publication Date
ATA575574A true ATA575574A (de) 1978-05-15

Family

ID=25765510

Family Applications (1)

Application Number Title Priority Date Filing Date
AT575574A ATA575574A (de) 1973-07-13 1974-07-11 Verfahren zur herstellung von neuen 1,3-oxygenierten 8alfa-oestratrienen

Country Status (18)

Country Link
JP (1) JPS5821639B2 (en, 2012)
AT (1) ATA575574A (en, 2012)
AU (1) AU477010B2 (en, 2012)
CA (1) CA1030951A (en, 2012)
CH (2) CH614217A5 (en, 2012)
CS (2) CS182260B2 (en, 2012)
DD (1) DD114066A5 (en, 2012)
DK (1) DK133051C (en, 2012)
ES (1) ES428226A1 (en, 2012)
FI (1) FI54131C (en, 2012)
FR (1) FR2236505B1 (en, 2012)
GB (1) GB1479934A (en, 2012)
HU (1) HU169791B (en, 2012)
IE (1) IE39872B1 (en, 2012)
IL (1) IL45259A (en, 2012)
NO (1) NO742546L (en, 2012)
SE (1) SE7409151L (en, 2012)
SU (1) SU626705A3 (en, 2012)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551214C2 (de) * 1975-11-12 1984-07-12 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen
JPS5862734U (ja) * 1981-10-22 1983-04-27 日工株式会社 型枠支持サボ−ト
JPS59146759A (ja) * 1984-01-06 1984-08-22 株式会社日立製作所 自動ねじ込み装置
JPS60155376A (ja) * 1984-01-24 1985-08-15 松下電器産業株式会社 ナツト浮き検出装置
DE3710728A1 (de) * 1987-03-31 1988-10-13 Schering Ag Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6903084B2 (en) 1991-08-28 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
RU2679625C1 (ru) * 2018-11-08 2019-02-12 Ильясов Шамиль Сионович ПРИМЕНЕНИЕ 3-О-СУЛЬФАМОИЛОКСИ-6-ОКСА-7β-МЕТИЛ-D-ГОМО-8α-ЭСТРА-1,3,5(10)-ТРИЕН-17а-ОНА ДЛЯ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ВКЛЮЧАЯ ТРИЖДЫ-НЕГАТИВНУЮ ФОРМУ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436411A (en) * 1967-12-28 1969-04-01 American Home Prod Process for cleaving an a-ring ether group in 13-alkylgona (and 8-isogona)-1,3,5(10)-trienes and delta-7-,delta-8(9)-,and delta-8(9),14(15)-dehydro derivatives thereof

Also Published As

Publication number Publication date
SU626705A3 (ru) 1978-09-30
AU7112374A (en) 1976-01-15
JPS5821639B2 (ja) 1983-05-02
IE39872B1 (en) 1979-01-17
IE39872L (en) 1975-01-13
DK368074A (en, 2012) 1975-03-17
FR2236505B1 (en, 2012) 1977-07-08
IL45259A0 (en) 1974-10-22
SE7409151L (sv) 1975-01-14
ES428226A1 (es) 1976-07-16
DK133051B (da) 1976-03-15
CH609064A5 (en) 1979-02-15
CS182260B2 (en) 1978-04-28
AU477010B2 (en) 1976-10-14
NO742546L (en, 2012) 1975-02-10
CA1030951A (en) 1978-05-09
HU169791B (en) 1977-01-28
DD114066A5 (en, 2012) 1975-07-12
DK133051C (da) 1976-08-16
GB1479934A (en) 1977-07-13
FI54131C (fi) 1978-10-10
FI54131B (fi) 1978-06-30
CH614217A5 (en) 1979-11-15
JPS5032160A (en, 2012) 1975-03-28
FI213974A7 (en, 2012) 1975-01-14
CS182300B2 (en) 1978-04-28
FR2236505A1 (en, 2012) 1975-02-07
IL45259A (en) 1977-10-31

Similar Documents

Publication Publication Date Title
AT337178B (de) Verfahren zur herstellung von neuen 1-hydroxy- und 1-alkanoyloxy-3-alkyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo(b,d)pyran-9-onen
AT336012B (de) Verfahren zur herstellung von neuen 1,9-dihydroxy- oder dialkanoyloxy-3-alkyl-6a,7,8,9,10,10a-hexahydro-6h-dibenzo(b,d)-pyranen
DD112443A5 (de) Verfahren zur herstellung von 2,2,6,6-tetramethyl-4-oxopiperidin
ATA575574A (de) Verfahren zur herstellung von neuen 1,3-oxygenierten 8alfa-oestratrienen
AT342556B (de) Verfahren zur herstellung von neuen 1,2,2,2-tetrafluorathylathern
AT340612B (de) Verfahren zur herstellung von neuen 25-hydroxycholesterinen
AT335607B (de) Verfahren zur herstellung von neuen beta-lactamantibiotica
AT342557B (de) Verfahren zur herstellung von neuen 2,2,2-trifluor-1-chlorathyl-athern
AT336580B (de) Verfahren zur herstellung von neuen 3-hydroxyacylaminomethyl-5-acylamino-2,4,6-trijodbenzoesauren
AT338240B (de) Verfahren zur herstellung von neuen phenoxyathylaminen
AT339606B (de) Verfahren zur herstellung von neuen, ketimingruppen enthaltenden prapolymeren
AT327904B (de) Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen
AT328452B (de) Verfahren zur herstellung von neuen 1,4-dihydrochinolinen
AT328467B (de) Verfahren zur herstellung von neuen 2,4-dienoxy-6- (alkoxysilylalkylamino) -s-triazinen
AT339283B (de) Verfahren zur herstellung von neuen 3,4-diamino-benzophenonen
DD129214A5 (de) Verfahren zur herstellung von neuen 1,9-dihydroxy-hexahydrodibenzopyranen
ATA299575A (de) Verfahren zur herstellung von neuen 3,4-dicarboxycephalosporinen
ATA146874A (de) Verfahren zur herstellung von neuen 1,4-dihydro-2h-isochinolinderivaten
ATA868776A (de) Verfahren zur herstellung von neuen 1,3-oxygenierten 8alfa-oestratrienen
AT327950B (de) Verfahren zur herstellung von neuen 1,2-oxaphospholanen
AT338423B (de) Verfahren zur herstellung von neuen 1,2,4-dithiaaz-3-enen
AT342066B (de) Verfahren zur herstellung von neuen 2-phenyl-4h-3,1-benzoxazinen
ATA141474A (de) Verfahren zur herstellung von neuen 1,1-diphenyl-3-aminopropanolen-(2)
AT341502B (de) Verfahren zur herstellung von neuen 3,4-diamino-benzophenonen
AT341685B (de) Verfahren zur herstellung von neuen 3',3''-didehydro- (cardenolid-3-tridigitoxosiden)

Legal Events

Date Code Title Description
A1Z Withdrawn